Total Assets: The sum of all assets on a company's balance sheet.
Xeris Biopharma Holdings, Inc. (XERS) had Total Assets of $383.53M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$291.85M |
|
$0.55M |
|
$42.57M |
|
$249.28M |
|
$266.95M |
|
$24.90M |
|
$-24.34M |
|
$0.55M |
|
$0.55M |
|
$0.55M |
|
$0.55M |
|
$0.55M |
|
$0.55M |
|
$24.90M |
|
$40.96M |
|
160.43M |
|
172.74M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$240.31M |
|
$4.95M |
|
$143.21M |
|
|
Total Assets |
$383.53M |
$109.57M |
|
$220.34M |
|
$260.26M |
|
$369.84M |
|
$13.69M |
|
$-97.25M |
|
$13.69M |
|
166.22M |
|
| Cash Flow Statement Financials | |
$28.63M |
|
$-0.70M |
|
$11.39M |
|
$75.74M |
|
$115.06M |
|
$39.32M |
|
$22.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.19 |
|
-- |
|
-- |
|
0.94 |
|
16.10 |
|
85.41% |
|
8.53% |
|
8.53% |
|
14.04% |
|
0.19% |
|
0.19% |
|
$27.93M |
|
-- |
|
-- |
|
-- |
|
0.76 |
|
0.62 |
|
5.72 |
|
63.85 |
|
4.05% |
|
-0.57% |
|
0.14% |
|
0.24% |
|
$0.08 |
|
$0.16 |
|
$0.17 |
|